CIK 0001623526 · Non-accelerated filer<br>Smaller reporting company
Stoke Therapeutics, Inc.
Sign in to watch- Ticker
- STOK
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 471144582
- Phone
- 781-430-8200
- Business address
- 45 WIGGINS AVENUE, BEDFORD, MA, 01730
- Former names
- ASOthera Pharmaceuticals, Inc.
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $1,050,832
- in 7 filings, $404K under 10b5-1 plans
Net −$1,050,832. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 79 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2023-09-19 | SMITH IAN F Director | Grant or award · Director Stock Option (Right to Buy) | +96,340 | 96,340 | ||
| 2023-07-03 | Ticho Barry Chief Medical Officer | Sale | −15,000 | $10.60 | $159K | 25,895 |
| 2023-06-21 | Allan Jonathan General Counsel & Corp Sec | Sale 10b5-1 | −1,948 | $13.48 | $26K | 0 |
| 2023-06-13 | TZIANABOS ARTHUR Director | Grant or award · Director Stock Option (Right to Buy) | +19,441 | 19,441 | ||
| 2023-06-13 | Smith Julie Director | Grant or award · Director Stock Option (Right to Buy) | +19,441 | 19,441 | ||
| 2023-06-13 | Menzel Garry E Director | Grant or award · Director Stock Option (Right to Buy) | +19,441 | 19,441 | ||
| 2023-06-13 | LEVIN ARTHUR A Director | Grant or award · Director Stock Option (Right to Buy) | +19,441 | 19,441 | ||
| 2023-06-13 | Krainer Adrian R. Director | Grant or award · Director Stock Option (Right to Buy) | +19,441 | 19,441 | ||
| 2023-06-13 | Harrison Seth Loring Director | Grant or award · Director Stock Option (Right to Buy) | +19,441 | 19,441 | ||
| 2023-06-13 | Burstein Jennifer Director | Grant or award · Director Stock Option (Right to Buy) | +19,441 | 19,441 | ||
| 2023-06-01 | Ticho Barry Chief Medical Officer | Sale | −15,000 | $11.13 | $167K | 40,895 |
| 2023-05-04 | Ticho Barry Chief Medical Officer | Sale | −653 | $10.00 | $7K | 55,895 |
| 2023-05-03 | Ticho Barry Chief Medical Officer | Sale | −24,697 | $10.14 | $250K | 56,548 |
| 2023-05-02 | Ticho Barry Chief Medical Officer | Sale | −5,513 | $10.00 | $55K | 81,245 |
| 2023-05-01 | Ticho Barry Chief Medical Officer | Sale | −24,967 | $10.00 | $250K | 86,758 |
| 2023-03-27 | Kaye Edward M. MD CEO | Option exercise | +20,000 | $0.60 | $12K | 45,000 |
| 2023-03-27 | Kaye Edward M. MD CEO | Option exercise · Employee Stock Option (right to buy) | −20,000 | 602,801 | ||
| 2023-03-15 | Allan Jonathan General Counsel & Corp Sec | Grant or award · Employee Stock Option (Right to Buy) | +44,800 | 44,800 | ||
| 2023-03-15 | Allan Jonathan General Counsel & Corp Sec | Grant or award · Restricted Stock Unit (RSU) | +29,900 | 29,900 | ||
| 2023-03-15 | Tulipano Stephen J CFO | Grant or award · Employee Stock Option (Right to Buy) | +78,600 | 78,600 |
Page 20 of 24 · 461 trades